DONATE BLOOD! Save lives and contribute to uninterrupted patient care! bit.ly/3b4pSDX #COVID #COVIDー19 #COVID19 #blooddoantion #donors

Our paper on BTK mutations in CLL is out in BJH: Screening and monitoring of the BTKC481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy onlinelibrary.wiley.com/doi/10.1111/bj…

Lili Kotmayer from our lab presenting her data on the GATA2 database generated in the framework of the GATA2HuMo consortium in Athens at the EWOG-MDS meeting. It will be online soon. Well done, Lili! Lili Kotmayer, Krisztián Miklós KÁLLAY M.D., Ph.D.

Poster presentation at #EHA2022 discussing #venetoclax resistance in #CLL. Happy to be here! :) Csaba Bödör Bedics Gábor Bence Bátai

#EHA2022 A great few days at EHA with my group in Vienna.

Our review on #GATA2 deficiency is out in the BJH! Done by the ERAPerMed GATA2 HuMo consortium led by Giorgetti Lab. Proud to be a part of this! :) Csaba Bödör Marcin Wlodarski onlinelibrary.wiley.com/doi/10.1111/bj…

Great meeting with colleagues from the Gata2 ERA-PerMed consortium in Barcelona. Thanks for your time: Giorgetti Lab Marcin Wlodarski Lili Kotmayer Oskar Marin Bejar

Correlating specific variants with risk is the holy grail of IMBFS/CPS research, but findings can be so fleeting. We will succeed only with determination, careful subsetting, and examining large cohorts as occurs through collaboration as shown by Lili Kotmayer #ASH2024 #HemeTwitter